scholarly journals Reliability and Validity of the Japanese Version of BEMIB Modified for Patients With Bipolar Disorder: a Self-rating Scale for Medication Adherence

2012 ◽  
Vol 3 (0) ◽  
pp. 26-32
Author(s):  
Tatsuya Tokura ◽  
Hiroyuki Kimura ◽  
Akira Yoshimi ◽  
Mitsuki Ohashi ◽  
Mie Masuda ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Medication Adherence ◽  
Rating Scale ◽  
Reliability And Validity ◽  
Japanese Version ◽  
Self Rating

Reliability and validity of Japanese version of Unified Multiple System Atrophy Rating Scale

2020 ◽  
Author(s):  
Ayaka Chikada ◽  
Jun Mitsui ◽  
Takashi Matsukawa ◽  
Hiroyuki Ishiura ◽  
Tatsushi Toda ◽  
...  
Keyword(s):  
Multiple System Atrophy ◽  
Rating Scale ◽  
Reliability And Validity ◽  
Japanese Version

scholarly journals Factor structure, reliability, and validity of the Japanese version of the Hoarding Rating Scale-Self-Report (HRS-SR-J)

2017 ◽  
Vol Volume 13 ◽  
pp. 1235-1243 ◽  
Author(s):  
Aki Tsuchiyagaito ◽  
Satoshi Horiuchi ◽  
Toko Igarashi ◽  
Yoshiya Kawanori ◽  
Yoshiyuki Hirano ◽  
...  
Keyword(s):  
Factor Structure ◽  
Rating Scale ◽  
Reliability And Validity ◽  
Japanese Version ◽  
Self Report ◽  
Structure Reliability

scholarly journals Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria

2018 ◽  
Vol 40 (2) ◽  
pp. 85-92 ◽  
Author(s):  
Godspower O. Owie ◽  
Sunday O. Olotu ◽  
Bawo O. James
Keyword(s):  
Medication Adherence ◽  
Rating Scale ◽  
Reliability And Validity ◽  
Cross Sectional Study ◽  
Sub Saharan Africa ◽  
Adherence Behavior ◽  
Good Reliability ◽  
Cross Sectional ◽  
Negative Side Effects ◽  
Sub Saharan

Abstract Introduction Assessing adherence in schizophrenia facilitates interventions that optimize outcomes. Adherence rating questionnaires are feasible and non-intrusive; however, no validated measure exists in sub-Saharan Africa. We aimed to assess the psychometric properties of the 10-item Medication Adherence Rating Scale (MARS). Methods This was a cross-sectional study of a cohort of patients with schizophrenia (n=230). A sociodemographic questionnaire, the Mini International Neuropsychiatric Interview (MINI), Positive and Negative Syndrome Scale (PANSS), Scale for the Unawareness of Mental Disorder (SUMD) and the MARS were all administered by an interviewer. Results The MARS demonstrated good reliability (Cronbach’s alpha: 0.76). The scale was reducible to a 3-factor construct (1 – medication adherence behavior, 2 – attitude to taking medications, and 3 – negative side effects and attitude to psychotropics), with significant though weak external validity in relation to psychopathology (p<0.001) and insight (p<0.001). The first factor showed good internal consistency (α=0.80), comprising six items that could serve as a reliable proxy measure of adherence in place of the MARS Conclusion The MARS demonstrated fair psychometric characteristics in assessing adherence in patients with schizophrenia in this cohort. The scale may be useful in the dimensional assessment of medication adherence for schizophrenia in sub-Saharan African settings.

scholarly journals Promoting medication adherence among patients with bipolar disorder: a multicenter randomized controlled trial of a multifaceted intervention

2017 ◽  
Vol 47 (14) ◽  
pp. 2528-2539 ◽  
Author(s):  
A. H. Pakpour ◽  
A. Modabbernia ◽  
C.-Y. Lin ◽  
M. Saffari ◽  
M. Ahmadzad Asl ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Medication Adherence ◽  
Motivational Interviewing ◽  
Rating Scale ◽  
Controlled Trial ◽  
Multifaceted Intervention ◽  
Mood Stabilizers ◽  
Care Group ◽  
Baseline Score ◽  
Multicenter Randomized Controlled Trial

BackgroundThe present research aimed to investigate the efficacy of a multifaceted intervention that included motivational interviewing (MI) and psychoeducation in improving medication adherence (MA) among patients with bipolar disorder (BD).MethodA multicenter, cluster randomized, observer-blind, controlled, parallel-group trial was conducted in ten academic centers in Iran. Patients with BD were randomly assigned to the experimental group (EXP; n = 136) or the usual care group (UC; n = 134). The EXP group received five sessions of MI and psychoeducation together with their family members. The primary outcome measure was changes in scores on the Medication Adherence Rating Scale from baseline to 6 months post-intervention. Other outcome measures included serum levels of mood stabilizers, clinical symptoms, quality of life, as well as measures of intention, beliefs about medicine, perceived behavioral control, automaticity, action and coping planning, and adverse reactions.ResultsMedication adherence improved over time in both groups, but patients in the EXP group improved more (baseline score: 6.03; score at the sixth month: 9.55) than patients in the UC group (baseline score: 6.17; score at the sixth month: 6.67). In addition, patients in the EXP group showed greater improvement than patients in the UC group in almost all secondary outcomes 6 months following the intervention.ConclusionsMultifaceted interventions that include motivational-interviewing and psychoeducation can significantly improve MA and clinical and functional outcomes in patients with BD.Trial Registration Number: The trial was registered with theClinicalTrials.gov database (NCT02241863) https://clinicaltrials.gov/ct2/show/NCT02241863

scholarly journals The McGill Pain Questionnaire - Japanese Version, Reconsidered: Confirming the Reliability and Validity

1996 ◽  
Vol 1 (4) ◽  
pp. 233-237 ◽  
Author(s):  
Mamoru Hasegawa ◽  
Suguru Hattori ◽  
Keiji Ishizaki ◽  
Shosuke Suzuki ◽  
Fumio Goto
Keyword(s):  
Chronic Pain ◽  
Rating Scales ◽  
Rating Scale ◽  
Pain Treatment ◽  
Reliability And Validity ◽  
Japanese Version ◽  
University Hospital ◽  
Mcgill Pain Questionnaire ◽  
Pain Rating ◽  
Pain Questionnaire

BACKGROUND:The McGill Pain Questionnaire (MPQ) is one of the most widely used instruments in the world to evaluate patients with chronic pain. However, differences in languages and cultural backgrounds have hindered its standardization in Japan.OBJECTIVE:To standardize the MPQ in Japan.DESIGN:The reliability and validity of a Japanese version of the MPQ (JMPQ) were examined using a translation-based methodology, which followed a format similar to the original MPQ.SETTING:Multidisciplinary pain treatment centre of a university hospital in Japan.PATIENTS:Consecutive out-patients (n=152) with chronic pain.METHODS:Each patient completed the JMPQ, other pain rating scales (visual analogue scale, verbal rating scale, numerical rating scale) and the state-trait anxiety inventory. A subset of these patients (n=40) were tested again two weeks later.RESULTS:Acceptable levels of reliability and validity of the JMPQ, and independence of the JMPQ subscales from other pain rating scales were confirmed by principal component analysis. Chronic pain patients did not show marked levels of anxiety as might have been expected.CONCLUSIONS:The findings suggest that the JMPQ possesses sufficient merits as a pain rating scale from the standpoint of its reliability and validity. Furthermore, it is suggested that the JMPQ can be used to measure qualitative aspects of pain transcending differences in linguistic characteristics.

Japanese Version of the Delirium Rating Scale, Revised–98 (DRS-R98–J): Reliability and Validity

2010 ◽  
Vol 51 (5) ◽  
pp. 425-431 ◽  
Author(s):  
Masashi Kato ◽  
Yasuhiro Kishi ◽  
Toru Okuyama ◽  
Paula T. Trzepacz ◽  
Takashi Hosaka
Keyword(s):  
Rating Scale ◽  
Reliability And Validity ◽  
Japanese Version
Sign in / Sign up

Export Citation Format

Share Document